glp-1 names 5 trends to expect in 2026: Expanded uses, oral options, and more GLP-1 Weight Loss Drugs: How
Description
Among those, 12% studies has results and 88% has no results available, which indicates towards an increasing interest in the cardiovascular effects of incretin-based therapies
In a surgically induced-OA model in rats, liraglutide also attenuated rat cartilage degeneration through suppressing the release of inflammatory mediators and protected chondrocytes against endoplasmic reticulum (ER) stress and apoptosis induced by interleukin-1 (IL-1) or triglycerides [46]
Who Should NOT Take Ozempic or Other GLP-1 Medications
Louis Aronne, a principal investigator on the clinical trial involving Zepbound and Wegovy, told ABC News that the success of drugs using tirzepatide is likely because the ingredient targets two hormones instead of one
doi: 10.1111/j.1440-1746.2008.05520.x
Chen SD, et al
